Basiliximab (Bas) induction negates the effect of a positive T cell cross match on acute rejection (ACR) rates in liver transplant(OLT) recipients receiving tacrolimus (Tac) based immunosuppression

HEPATOLOGY(2006)

引用 0|浏览4
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要